Imatinib and beyond—exploring the full potential of targeted therapy for CML - Quintás-Cardama, Alfonso; Kantarjian, Hagop; Cortes, Jorge (Nature reviews. Clinical oncology, 2009)
Keywords: Antineoplastic Agents - therapeutic use; Benzamides; Chronic myeloid leukemia; Clinical Trials as Topic; Disease Progression; Dose-Response Relationship, Drug; Drug therapy; Follow-Up Studies; Health aspects; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics; Medicine; Medicine & Public Health; Oncology; Patient outcomes; Piperazines - therapeutic use; Protein Kinase Inhibitors - therapeutic use; Protein tyrosine kinase; Pyrimidines - therapeutic use; review-article; Time Factors; Treatment Outcome; United States